Total Brain Ltd
ASX:TTB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
INOX Leisure Ltd
NSE:INOXLEISUR
|
IN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (25.5), the stock would be worth AU$-0.44 (22 103% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.1 | AU$0 |
0%
|
| Industry Average | 25.5 | AU$-0.44 |
-22 103%
|
| Country Average | 16.5 | AU$-0.29 |
-14 376%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Total Brain Ltd
ASX:TTB
|
267.4k AUD | -0.1 | -0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.1B USD | 14 | 54.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 7.8 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.4B USD | 0 | 12.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.9B EUR | 9.5 | 18.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23B EUR | 9.1 | 23.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.4B USD | 12.2 | 22.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.4B USD | 12.2 | 25.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 5.4 | 11.2 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.7B USD | -30.7 | -28.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 7.2 | 14 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 16.5 |
| 70th Percentile | 24.5 |
| Max | 6 797.5 |
Other Multiples
Total Brain Ltd
Glance View
Total Brain Ltd. engages in the provision of brain function analysis services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2001-08-28. The firm's Total Brain platform is a neuroscience-based mental health and brain performance solution that starts with a self-monitoring and self-care app for individuals that drives robust team analytics for companies and ongoing monitoring for providers. The firm's Total Brain app allows individuals to self-monitor brain capacities, screen for mental health risks, and improve overall mental health and brain performance with self-care exercises to improve overall brain capacity and mental health. The Total Brain app functions include self-monitoring brain capacities and mental state; screen for risk of common mental conditions; personalized self-care recommendations for improved mental health, and in-the-moment stress relief.
